|
Back to Home » May 2021 News » Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office |
Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office |
May 24, 2021
LAUSANNE, Switzerland, May 24, 2021 /PRNewswire/ -- Gnubiotics Sciences SA (Gnubiotics), a Swiss biotech company pioneering novel microbiome targeted solutions for humans and companion animals, today announced the allowance from the European Patent Office (EPO) for its patent application...
Source URL: https://www.prnewswire.com:443/news-releases/gnubiotics-gains-allowance-of-patent-of-microbiome-markers-for-prediction-identification-and-treatment-of-pet-obesity-from-the-european-patent-office-301297533.html
|
|
|
|
